Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in VZV-seronegative transplant recipients
NCT03685682Phase 3Completed
- Sponsor
- University Health Network
- Start
- May 2018
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Zoster vaccine recombinant in chickenpox, herpes zoster (HZ), sponsored by University Health Network. Started May 2018; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
chickenpoxherpes zoster (HZ)
Beyond the preview
Go deeper on NCT03685682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685682.